ArticleScience immunology2021

A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.

Maria Pino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.